In a recent metanalysis, including 19 studies, the mutated TERT promoter was associated with a significantly worse overall survival (hazard ratio 1.43, 95% CI 1.05–1.95), suggesting a major role for telomerase in malignant tumors [22]. This evidence concerns the gene TERT and cancer.